See our coverage of this Irvine, Calif., maker of devices for treating heart attacks in today’s daily briefing at VentureBeat Life Sciences.
TherOx raises $30M for hypersaturated-oxygen devices
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.